Old Web
English
Sign In
Acemap
>
authorDetail
>
Alexander J. Zoroufy
Alexander J. Zoroufy
Mayo Clinic
Medicine
Pathology
Oncology
Internal medicine
Cancer research
3
Papers
18
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 and COMET-2.
2021
Quality of Life Research
Gina L. Mazza
M. Petersen
Brenda Ginos
Blake T. Langlais
Narre Heon
Mrinal M. Gounder
Michelle R. Mahoney
Alexander J. Zoroufy
Gary K. Schwartz
Lauren J. Rogak
Gita Thanarajasingam
Ethan Basch
Amylou C. Dueck
Show All
Source
Cite
Save
Citations (1)
Alliance A091404: A phase II study of enzalutamide (NSC# 766085) for patients with androgen receptor-positive salivary cancers.
2019
Journal of Clinical Oncology
Alan Loh Ho
Nathan R. Foster
Alexander J. Zoroufy
Francis P. Worden
Katharine A. Price
Douglas Adkins
Daniel W. Bowles
Hyunseok Kang
Barbara Burtness
Eric J. Sherman
Roscoe F. Morton
Nora Katabi
Pamela N. Munster
Gary K. Schwartz
Show All
Source
Cite
Save
Citations (14)
A phase I/II trial adding poly(ADP-ribose) polymerase (PARP) inhibitor veliparib to induction carboplatin-paclitaxel (Carbo-Tax) in patients with head and neck squamous cell carcinoma (HNSCC) Alliance A091101.
2018
Journal of Clinical Oncology
Michael J. Jelinek
Nathan R. Foster
Alexander J. Zoroufy
Jonas A. De Souza
Gary K. Schwartz
Pamela N. Munster
Tanguy Y. Seiwert
Everett E. Vokes
Show All
Source
Cite
Save
Citations (3)
1